Sector News

Illumina Names Sanjay Chikarmane as Senior Vice President and General Manager of Enterprise Informatics

July 21, 2015
Life sciences
(BUSINESS WIRE) – Illumina Inc.  today announced that Sanjay Chikarmane has been named Senior Vice President and General Manager of Illumina’s Enterprise Informatics business. Chikarmane will lead the development and commercialization of products and services aimed at turning genomic data into actionable information for researchers and clinicians. He will report to Illumina President, Francis deSouza.
 
“Given the growing data intensive demands of the genomics market, we felt it critical to bring in a group leader dedicated to driving our informatics strategy,” said Francis deSouza, President of Illumina. “Sanjay is an excellent addition to Illumina’s leadership team and will be instrumental in growing our enterprise informatics business, defining our software development processes and service delivery architecture that will be used across all of Illumina.”
 
Nick Naclerio who led the acquisition of NextBio and served as the founding General Manager of the Enterprise Informatics business unit will return to the full-time role of Senior Vice President of Corporate Development.
 
Chikarmane joins Illumina with more than 20 years of experience in enterprise software at companies including HP, BEA Systems and most recently, SAP. Through his career, he has held a variety of leadership roles in enterprise software, including general management, go-to-market, product management and product development, during which he has successfully created and scaled several market leading products. While at SAP, Chikarmane oversaw several key products including industry solutions for big data analytics on the HANA platform, cloud business networks, data management and middleware, including their adoption by top customers.
 
Chikarmane holds a Bachelor of Technology degree in Electrical Engineering from the Indian Institute of Technology (IIT), Bombay, India and a Master of Science in Computer Engineering from Syracuse University.
 
Source: Illumina

comments closed

Related News

September 7, 2024

UAE MoHAP and Novo Nordisk partner for obesity management

Life sciences

The United Arab Emirates (UAE) Ministry of Health and Prevention (MoHAP) has established a partnership with Novo Nordisk Pharma Gulf focusing on the creation of a national scientific guide for obesity management and weight control. The collaboration also aims to enhance public awareness of cardiovascular diseases and their complications.

September 7, 2024

Lilly partners with Haya for lncRNA obesity target deal worth $1bn

Life sciences

Pharma giant Eli Lilly is teaming up with Haya Therapeutics in a $1bn deal to find multiple regulatory-genome-derived RNA-based drug targets, as it eyes up new targets in obesity. Under the deal, the companies will use Haya’s proprietary regulatory genome discovery platform to identify and validate long non-coding RNA (lncRNA) targets for developing potential treatments for obesity and related metabolic disorders.

September 7, 2024

Ashland completes sale of nutraceuticals business

Life sciences

The sale includes custom formulation and contract manufacturing capabilities for the nutrition market from the production facilities in New Jersey and Utah in the United States, and Tamaulipas, Mexico. Financial terms of the transaction were not disclosed.